Visage Imaging Debuts AI Offerings at Chicago Show

Visage Imaging, Inc. (Richmond, VIC, Australia) debuted its artificial intelligence (AI) offerings at the Radiological Society of North America (RSNA) 2017 annual meeting as part of the inaugural RSNA Machine Learning Showcase (November 26-30, Chicago, Illinois).

Visage aims to utilize its R&D capability and market leading technology to deliver cutting-edge AI offerings to optimize Enterprise Imaging worldwide. At RSNA 2017, the company showcased Visage 7 and the technology, which makes it the first and only system to combine both AI research and AI-assisted diagnostic interpretation in the same Enterprise Imaging platform.


“Historically, imaging platforms for research and diagnostic purposes have been totally separate. Visage’s GPU-based architecture is ideal for AI and, combined with our open APIs, will enable us to unify research and diagnostic imaging in ways not available before,” said Malte Westerhoff, PhD, co-founder and global CTO of Visage Imaging. “This will enable AI breakthroughs to advance patient care by giving radiologists faster access to new tools that help increase productivity and improve clinical accuracy.”

The company will also show algorithms working on the ultrafast and highly scalable Visage 7 Enterprise Imaging Platform. Both internally developed algorithms as well as third party algorithms from academic institutions and other companies will be demonstrated.

“AI is evolving rapidly and has the potential to transform Enterprise Imaging in ways previously not imagined,” said Dr. Sam Hupert, CEO of Visage Imaging. “We are well placed to capitalize on this transformation as we look to leverage our three key assets, namely our R&D capability, our technology platform and our growing base of blue chip clients.”

The company’s first AI innovations for Visage 7 are works-in-progress and are scheduled to be released in the first half of 2018.